Pfizer's Q3 results are due on Nov. 4, with analysts eyeing $16.6B in sales and EPS of 66 cents as investors weigh the ...

Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range from $13.0 to $26.5 for Pfizer over the last 3 months.

Michael Burry shorts Nvidia and Palantir, stoking AI bubble fears. Scion’s $1.1B puts shake markets. NVDA and PLTR rally over ...

Discover top large-cap value stocks using YCharts & Ben Graham Formula. Find high-yield dividend picks for October 2024.

Despite a headline beat and decent revenue forecast, the poor reaction to the update from AI and data analytics darling ...

Viking Therapeutics is mispriced due to the successful but misunderstood clinical results of their oral GLP-1 treatment. Read ...

Michael Burry, the investor made famous by The Big Short for predicting the 2008 financial crisis, has once again captured public attention with his latest moves on Wall Street. This time, he is ...

Eli Lilly and Novo Nordisk are expected to announce price reductions for their weight-loss drugs as part of the TrumpRx ...

Risky assets slid, with tech stocks and cryptocurrencies bearing the brunt of the selling, after long-simmering concerns ...

In the competitive world of small-cap biotechnology, CorMedix CRMD and Theravance Biopharma TBPH stand out as two companies ...

Subscribe to the Stock Movers Podcast on Apple ... Loop Capital Markets on Monday raised its price target to a Street-high view of $350, up from $250. Alphabet Inc. is looking at selling about $15 ...

Pfizer files lawsuits against Novo over $9B Metsera bid, challenging 30-month timeline. Court hearing Tuesday as deadline ...